Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Atyr Pharma Inc’s stock clocked out at $3.97, down -0.25% from its previous closing price of $3.98. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 1.36 million shares were traded. ATYR stock price reached its highest trading level at $4.225 during the session, while it also had its lowest trading level at $3.895.
Ratios:
To gain a deeper understanding of ATYR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.
On October 04, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.
On September 05, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $9.Jefferies initiated its Buy rating on September 05, 2024, with a $9 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 24 ’24 when SCHIMMEL PAUL bought 52,300 shares for $1.93 per share. The transaction valued at 101,038 led to the insider holds 413,023 shares of the business.
SCHIMMEL PAUL bought 41,052 shares of ATYR for $71,500 on Jul 22 ’24. The Director now owns 354,075 shares after completing the transaction at $1.74 per share. On Jul 23 ’24, another insider, SCHIMMEL PAUL, who serves as the Director of the company, bought 6,648 shares for $1.82 each. As a result, the insider paid 12,075 and bolstered with 360,723 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 333251328 and an Enterprise Value of 280648352. For the stock, the TTM Price-to-Sale (P/S) ratio is 1474.86 while its Price-to-Book (P/B) ratio in mrq is 4.61. Its current Enterprise Value per Revenue stands at 1194.248 whereas that against EBITDA is -4.167.
Stock Price History:
The Beta on a monthly basis for ATYR is 1.10, which has changed by 1.5189874 over the last 52 weeks, in comparison to a change of 0.24933672 over the same period for the S&P500. Over the past 52 weeks, ATYR has reached a high of $4.02, while it has fallen to a 52-week low of $1.39. The 50-Day Moving Average of the stock is 20.31%, while the 200-Day Moving Average is calculated to be 79.06%.
Shares Statistics:
It appears that ATYR traded 1.09M shares on average per day over the past three months and 1026150 shares per day over the past ten days. A total of 83.94M shares are outstanding, with a floating share count of 81.96M. Insiders hold about 2.36% of the company’s shares, while institutions hold 63.01% stake in the company. Shares short for ATYR as of 1734048000 were 2920070 with a Short Ratio of 2.69, compared to 1731628800 on 2114376. Therefore, it implies a Short% of Shares Outstanding of 2920070 and a Short% of Float of 4.58.
